98%
921
2 minutes
20
Frequent glucose monitoring is essential for effective diabetes management. Currently, glucose monitoring is done using invasive methods such as finger-pricking and subcutaneous sensing. However, these methods can cause discomfort, heighten the risk of infection, and some sensing devices need frequent calibration. Non-invasive glucose monitoring technologies have attracted significant attention due to their potential to overcome the limitations of their invasive counterparts by offering painless and convenient alternatives. This review focuses on two prominent approaches to non-invasive glucose sensing: optical- and microwave-based methods. On one hand, optical techniques, including Raman and near-infrared (NIR) spectroscopy, leverage the unique spectral properties of glucose molecules to measure their concentration in tissues and biofluids. On the other hand, microwave sensing leverages the dielectric properties of glucose to detect concentration changes based on impedance measurements. Despite their promise, optical- and microwave-based technologies face challenges such as signal interference and high variability due to tissue heterogeneity, which impact their accuracy and reliability. This review provides a comprehensive overview of the advancements of these non-invasive methods, highlighting their technical implementation, limitations, and their future potential in revolutionizing glucose monitoring for diabetes care.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bios.2024.117081 | DOI Listing |
Diabetes Ther
September 2025
Department of Diabetes and Endocrinology, Guy's and St Thomas' NHS Trust, London, UK.
Introduction: This post hoc analysis of an A Toujeo Observational Study (ATOS) aims to evaluate the real-world effectiveness and safety of insulin glargine 300 U/ml (Gla-300) in high-risk subgroups of insulin-naïve people with type 2 diabetes (PwT2D) from multiple geographical regions (Asia, the Middle East, North Africa, Latin America, and Eastern Europe).
Methods: In these post hoc analyses of ATOS, a real-world, 12-month, prospective study included 4422 insulin-naïve adults (age ≥ 18 years) with type 2 diabetes (T2D) uncontrolled (HbA > 7% and ≤ 11%) on one or more oral antidiabetic drugs (OADs) who initiated Gla-300 treatment as per routine practice. Primary and secondary endpoints were studied according to renal impairment (RI) status (without or with) and age group (≥ 70 years).
Chem Senses
September 2025
Rutgers University Department of Nutritional Sciences. 65 Dudley Road, New Brunswick, NJ 08901, USA.
Recent research has shown that KATP channels in mouse taste bud cells enhance glucose taste signaling by depolarizing the cell when ATP is present. Relatedly, estradiol has been shown to enhance glucose sensing in human pancreatic β cells via closure of KATP channels. Since taste tissue has estradiol receptors, we linked these two observations and tested whether elevated estradiol may also enhance taste sensitivity and liking for glucose in humans.
View Article and Find Full Text PDFJ Clin Nurs
September 2025
Department of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.
Background: Low-value care provides little or no benefit to patients, or its risk of harm outweighs the potential benefits. Non-nursing tasks refer to tasks performed by nurses below their scope of practice. With increasing pressure on the global nursing workforce, it is necessary to identify these concepts to deliver fundamental care.
View Article and Find Full Text PDFDiabetes Obes Metab
September 2025
Department of Pediatrics, Diabetes Research Institute, IRCCS San Raffaele, Milan, Italy.
Cureus
August 2025
Department of Neurology, National Hospital Organization Disaster Medical Center, Tokyo, JPN.
Bacterial meningitis and infectious cavernous sinus thrombosis (CST) are both life-threatening central nervous system infections, often caused by sinusitis. While cerebrovascular complications are well-recognized in bacterial meningitis, their association with CST is rare. A 69-year-old man presented with a 19-day history of headache, followed by diplopia.
View Article and Find Full Text PDF